About Stanley Marks
Stanley Marks is a board chairman at Duo Oncology.
Form D filings also name Stanley Marks as a director at SirnaMed Therapeutics.
Stanley Marks first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Stanley Marks in the role, so the role may have started earlier or lasted longer.
Duo Oncology Inc.
Board Chairman
2021 – 2026 · Pittsburgh, PA
Develops combination chemotherapy medicines for people with cancer.
Key Colleagues at Startups
The people Stanley Marks works with at each company, as listed on that company's latest Form D.
Duo Oncology Inc. · Form D/A, Aug 7, 2026
JH
Jing-Zhou Hou
Co-Founder and director
Sam Rothstein
CEO & Cofounder, director
ST
Stephen Thorne
Executive officer and promoter
Victoria Manax
Medical Officer and director
SL
Song Li
Co-Founder and director
Katherine Eichinger
Chief Operating Officer
Joe Gatto
Director
LL
Lusong Luo
Member - BeOne Medicines and director
SirnaMed Therapeutics Inc. · Form D, Jul 25, 2024
PT
Phong Tran
Executive officer
JH
Jing-Zhou Hou
Treasurer and director
SL
Song Li
Executive officer, director and promoter